MILLER, MICHAEL,BASU, KALLOL,DEMONG, DUANE,SCOTT, JACK,LI, WEI,HARRIS, JOEL,STAMFORD, ANDREW,POIRIER, MARC,TEMPEST, PAUL
申请号：
EP14761134
公开号：
EP2964222A4
申请日:
2014.02.27
申请国别(地区):
EP
年份:
2016
代理人:
摘要：
The present invention is directed to indazole compounds which are potent inhibitors of LRRK2 kinase and useful in the treatment or prevention of diseases in which the LRRK2 kinase is involved, such as Parkinson's Disease. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which LRRK-2 kinase is involved.
